Speech-Language Pathologists in Cheney, WA Accepting Medicare

8 Speech-Language Pathologists found. Showing 1 - 8

Mrs. April Montney-codr, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2219 N 6th St, Cheney, WA 99004 Phone: 208-739-6065

Mrs. Deanna Marie Mccabe, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6323 S Holly Rd, Cheney, WA 99004 Phone: 509-559-4326

Mrs. Jennifer Lynn Omlin, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11622 S Scribner Rd, Cheney, WA 99004 Phone: 509-499-0561

Roxanne M Adsero, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9712 W 72nd Ave, Cheney, WA 99004 Phone: 509-468-0928

Michelle Manley, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 210 W Paradise Rd, Cheney, WA 99004 Phone: 509-994-5541

Carly B Jackson, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12414 S Andrus Rd, Cheney, WA 99004 Phone: 509-559-4507    Fax: 509-559-4517

Gretchen Stephens, MS CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12414 S Andrus Rd, Cheney, WA 99004 Phone: 509-559-4599

Erika Johnson Klauss, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 520 4th St, Cheney, WA 99004 Phone: 509-559-4507

News Archive

Astellas Pharma and XenoPort submit NDA in Japan for PMDA approval

Astellas Pharma Inc. and XenoPort, Inc. today announced that a new drug application (NDA) has been filed with the Pharmaceuticals and Medical Device Agency (PMDA) in Japan for ASP8825 (gabapentin enacarbil), also known as XP13512, as a potential treatment for restless legs syndrome (RLS).

Study explains why men are more at risk for neurodevelopmental disorders

A new study has shed light on the reason why males are more at risk than females for neurodevelopmental disorders such as autism, schizophrenia and ADHD.

Study on immune system activation may help develop new drugs for infections

A new research report in the October 2010 print issue of the Journal of Leukocyte Biology sheds important light on how our immune systems detect invading organisms to be destroyed and removed from our bodies. The information from this research should ultimately help lead to the development of new drugs and treatments that allow health care providers to prevent runaway immune reactions that can have devastating consequences for people.

Fixing wrist fractures without a cast

It is prime season for wrist fractures. Ice and snow covered streets are the main culprits as victims instinctively reach out their hands to break a fall.

Penwest confirms action on Oxymorphone patent application

Penwest Pharmaceuticals has confirmed that the U.S. Patent and Trademark Office (PTO) has posted on its website an indication that a final rejection of Penwest's patent application claiming the sustained release formulations of Oxymorphone will be mailed.

Read more Medical News

› Verified 1 days ago